CHARACTERIZATION OF MUTATIONS IN ASXL1, SRSF2, CBL AND JAK2 GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA

被引：0
|
作者：
Palomo, L. [1 ]
Xicoy, B. [2 ]
Marce, S. [2 ]
Garcia, O. [2 ]
Cabezon, M. [2 ]
Jimenez, M. [2 ]
Arnan, M. [3 ]
Pomares, H. [3 ]
Alonso, E. [3 ]
Granada, I. [2 ]
Ribera, J. [2 ]
Sole, F. [1 ]
Ribera, J. [2 ]
Feliu, E. [2 ]
Milla, F. [2 ]
Zamora, L. [2 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Josep Carreras Leukaemia Res Inst, Myelodysplast Syndromes Grp, Badalona, Spain
[2] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Josep Carreras Leukaemia Res Inst ICO, Hematol, Badalona, Spain
[3] Hosp Duran & Reynals, ICO, Hematol, Barcelona, Spain
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P262
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [41] Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
    Abdel-Wahab, O.
    Pardanani, A.
    Patel, J.
    Wadleigh, M.
    Lasho, T.
    Heguy, A.
    Beran, M.
    Gilliland, D. G.
    Levine, R. L.
    Tefferi, A.
    LEUKEMIA, 2011, 25 (07) : 1200 - 1202
  • [42] Interrogating the Role of ASXL1 and JAK2 mutations in Myeloproliferative Neoplasms Utilizing Human Pluripotent Stem Cells
    Collins, Taylor B.
    Luff, Stephanie A.
    Batista, Luis F. Z.
    Sturgeon, Christopher M.
    Oh, Stephen T.
    BLOOD, 2019, 134
  • [43] Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Pardanani, Animesh
    Patel, Jay
    Lasho, Terra
    Heguy, Adriana
    Levine, Ross
    Tefferi, Ayalew
    BLOOD, 2010, 116 (21) : 1266 - 1266
  • [44] Mutational Screening Of CSF3R, ASXL1, SETBP1, and SRSF2 In Chronic Neutrophilic Leukemia (CNL), Atypical CML and CMML Cases
    Meggendorfer, Manja
    Alpermann, Tamara
    Haferlach, Torsten
    Schrauder, Carina
    Konietschke, Rabea
    Haferlach, Claudia
    Kern, Wolfgang
    Schnittger, Susanne
    BLOOD, 2013, 122 (21)
  • [45] ASXL1 and SETBP1 Mutations and Their Prognostic Contribution In Chronic Myelomonocytic Leukemia: An International Study Of 431 Patients
    Patnaik, Mrinal M.
    Itzykson, Raphael
    Lasho, Terra L.
    Kosmider, Olivier
    Finke, Christy
    Hanson, Curtis A.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Tefferi, Ayalew
    Solary, Eric
    BLOOD, 2013, 122 (21)
  • [46] Screening for ASXL1 and SRSF2 mutations is imperative for treatment decision-making in otherwise low or intermediate-1 risk patients with myelofibrosis
    Tefferi, Ayalew
    Lasho, Terra L.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Gangat, Naseema
    Pardanani, Animesh
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (04) : 678 - 681
  • [47] In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia
    Geissler, Klaus
    Jaeger, Eva
    Barna, Agnes
    Sliwa, Thamer
    Knoebl, Paul
    Schwarzinger, Ilse
    Gisslinger, Heinz
    Valent, Peter
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) : 562 - 567
  • [48] ASXL1 and SETBP1 Mutations and Their Prognostic Contribution in Chronic Myelomonocytic Leukemia: An International Study of 466 Patients
    Patnaik, Mrinal M.
    Itzykson, Raphael
    Lasho, Terra L.
    Kosmider, Olivier
    Finke, Christy M.
    Hanson, Curtis A.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Tefferi, Ayalew
    Solary, Eric
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S234 - S234
  • [49] SRSF2 is Mutated in 47.2% (77/163) of Chronic Myelomonocytic Leukemia (CMML) and Prognostically Favorable in Cases with Concomitant RUNX1 mutations
    Schnittger, Susanne
    Meggendorfer, Manja
    Kohlmann, Alexander
    Grossmann, Vera
    Yoshida, Kenichi
    Ogawa, Seishi
    Koeffler, H. Phillip
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    BLOOD, 2011, 118 (21) : 126 - 126
  • [50] Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS
    Kanagal-Shamanna, Rashmi
    Luthra, Rajyalakshmi
    Yin, Cameron C.
    Patel, Keyur P.
    Takahashi, Koichi
    Lu, Xinyan
    Lee, John
    Zhao, Chong
    Stingo, Francesco
    Zuo, Zhuang
    Routbort, Mark J.
    Singh, Rajesh R.
    Fox, Patricia
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos E.
    ONCOTARGET, 2016, 7 (12) : 14251 - 14258
12345